相关实验视频

Updated: Jan 8, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

利用多模式数据驱动的网络分析来确定SOX2-依赖状细胞肺癌的单疗法和组合疗法标

Woochang Hwang^1,2,3, Daniel Kottmann⁴, Wenrui Guo⁴

¹Milner Therapeutics Institute, University of Cambridge, Cambridge, UK.

Communications chemistry

|December 13, 2025

概括

我们创建了iPANDDA,这是一个计算工具,用于整合多模式数据以识别药物目标. 这种方法成功地确定了SOX2依赖的标,如AKT和mTOR,用于治疗肺状细胞癌.

科学领域:

计算生物学是一种计算生物学.
基因组学就是基因组学.
在瘤学瘤学.

背景情况:

药物发现需要了解复杂的疾病机制.
整合多模式数据 (omics,疾病,途径) 对于治疗见解至关重要.
由于模型有限,肺状细胞癌 (LUSC) 缺乏向治疗.

研究的目的:

开发一个计算管道 (iPANDDA) 集成多模式数据.
预测和验证特定疾病的候选药物标,重点是LUSC.
确定针对LUSC.中的SOX2基因的治疗策略.

主要方法:

开发了iPANDDA,一个基于网络的计算管道.
综合的OMIC,疾病相关和途径数据.
将iPANDDA应用于LUSC,专注于SOX2放大瘤.

主要成果:

在LUSC.中,iPANDDA成功地确定了SOX2依赖的治疗点.
在体外研究中验证了AKT和mTOR复合体作为关键标.
发现了SOX2驱动的LUSC潜在的单疗法和组合疗法策略.

结论:

iPANDDA 是一种有效的工具,用于药物发现中的多模式数据集成.
准SOX2,AKT和mTOR为LUSC提供了有前途的治疗途径.
这项研究为开发向LUSC治疗提供了一个框架.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...